Evidence map›Paper›PMID 34321995›Full record

ArticleFrontiers in neuroscience2021

MRI Radiomic Signature of White Matter Hyperintensities Is Associated With Clinical Phenotypes.

Martin Bretzner, Anna K Bonkhoff, Markus D Schirmer, Sungmin Hong, Adrian V Dalca, Kathleen L Donahue, Anne-Katrin Giese, Mark R Etherton, Pamela M Rist, Marco Nardin and 46 more

Abstract read
In one paragraph

Article in Frontiers in neuroscience, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

56 authors.

Martin BretznerJ. Philip Kistler Stroke Research Center, Massachusetts General Hospital, Boston, MA, United States.
Anna K BonkhoffJ. Philip Kistler Stroke Research Center, Massachusetts General Hospital, Boston, MA, United States.
Markus D SchirmerJ. Philip Kistler Stroke Research Center, Massachusetts General Hospital, Boston, MA, United States.
Sungmin HongJ. Philip Kistler Stroke Research Center, Massachusetts General Hospital, Boston, MA, United States.
Adrian V DalcaJ. Philip Kistler Stroke Research Center, Massachusetts General Hospital, Boston, MA, United States.
Kathleen L DonahueJ. Philip Kistler Stroke Research Center, Massachusetts General Hospital, Boston, MA, United States.
Anne-Katrin GieseJ. Philip Kistler Stroke Research Center, Massachusetts General Hospital, Boston, MA, United States.
Mark R EthertonJ. Philip Kistler Stroke Research Center, Massachusetts General Hospital, Boston, MA, United States.
Pamela M RistJ. Philip Kistler Stroke Research Center, Massachusetts General Hospital, Boston, MA, United States.
Marco NardinJ. Philip Kistler Stroke Research Center, Massachusetts General Hospital, Boston, MA, United States.
Razvan MarinescuJ. Philip Kistler Stroke Research Center, Massachusetts General Hospital, Boston, MA, United States.
Clinton WangJ. Philip Kistler Stroke Research Center, Massachusetts General Hospital, Boston, MA, United States.
Robert W RegenhardtJ. Philip Kistler Stroke Research Center, Massachusetts General Hospital, Boston, MA, United States.
Xavier LeclercInserm, CHU Lille, U1172 - LilNCog (JPARC) - Lille Neurosciences and Cognition, University of Lille, Lille, France.
Renaud LopesInserm, CHU Lille, U1172 - LilNCog (JPARC) - Lille Neurosciences and Cognition, University of Lille, Lille, France.
Oscar R BenaventeDepartment of Medicine, Division of Neurology, University of British Columbia, Vancouver, BC, Canada.
John W ColeDepartment of Neurology, University of Maryland School of Medicine and Veterans Affairs Maryland Health Care System, Baltimore, MD, United States.
Amanda DonattiSchool of Medical Sciences, University of Campinas (UNICAMP) and the Brazilian Institute of Neuroscience and Neurotechnology (BRAINN), Campinas, Brazil.
Christoph J GriessenauerDepartment of Neurosurgery, Geisinger, Danville, PA, United States.
Laura HeitschDivision of Emergency Medicine, Washington University School of Medicine, St. Louis, MO, United States.
Lukas HolmegaardInstitute of Biomedicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
Katarina JoodInstitute of Biomedicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
Jordi Jimenez-CondeDepartment of Neurology, Neurovascular Research Group (NEUVAS), Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Universitat Autonoma de Barcelona, Barcelona, Spain.
Steven J KittnerDepartment of Neurology, University of Maryland School of Medicine and Veterans Affairs Maryland Health Care System, Baltimore, MD, United States.
Robin LemmensDepartment of Neurosciences, Experimental Neurology and Leuven Research Institute for Neuroscience and Disease (LIND), KU Leuven - University of Leuven, Leuven, Belgium.
Christopher R LeviSchool of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia.
Patrick F McArdleDivision of Endocrinology, Diabetes and Nutrition, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, United States.
Caitrin W McDonoughDepartment of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, University of Florida, Gainesville, FL, United States.
James F MeschiaDepartment of Neurology, Mayo Clinic, Jacksonville, FL, United States.
Chia-Ling PhuahDepartment of Neurology, Washington University School of Medicine and Barnes-Jewish Hospital, St. Louis, MO, United States.
Arndt RolfsCentogene AG, Rostock, Germany.
Stefan RopeleDepartment of Neurology, Clinical Division of Neurogeriatrics, Medical University of Graz, Graz, Austria.
Jonathan RosandHenry and Allison McCance Center for Brain Health, Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, United States.
Jaume RoquerDepartment of Neurology and Evelyn F. McKnight Brain Institute, Miller School of Medicine, University of Miami, Miami, FL, United States.
Tatjana RundekDepartment of Neurology and Evelyn F. McKnight Brain Institute, Miller School of Medicine, University of Miami, Miami, FL, United States.
Ralph L SaccoDepartment of Neurology and Evelyn F. McKnight Brain Institute, Miller School of Medicine, University of Miami, Miami, FL, United States.
Reinhold SchmidtDepartment of Neurology, Clinical Division of Neurogeriatrics, Medical University of Graz, Graz, Austria.
Pankaj SharmaInstitute of Cardiovascular Research, Royal Holloway University of London (ICR2UL), Egham, United Kingdom.
Agnieszka SlowikDepartment of Neurology, Jagiellonian University Medical College, Krakow, Poland.
Alessandro SousaDepartment of Neurology, University of Maryland School of Medicine and Veterans Affairs Maryland Health Care System, Baltimore, MD, United States.
Tara M StanneInstitute of Biomedicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
Daniel StrbianDivision of Neurocritical Care and Emergency Neurology, Department of Neurology, Helsinki University Central Hospital, Helsinki, Finland.
Turgut TatlisumakDepartment of Clinica Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
Vincent ThijsStroke Division, Florey Institute of Neuroscience and Mental Health, Department of Neurology Austin Health, Heidelberg, VIC, Australia.
Achala VagalDepartment of Radiology, University of Cincinnati College of Medicine, Cincinnati, OH, United States.
Johan WasseliusDepartment of Clinical Sciences Lund, Radiology, Lund University, Lund, Sweden.
Daniel WooDepartment of Neurology and Rehabilitation Medicine, University of Cincinnati College of Medicine, Cincinnati, OH, United States.
Ona WuA. A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.
Ramin ZandDepartment of Neurology, Geisinger, Danville, PA, United States.
Bradford B WorrallDepartment of Neurology and Public Health Sciences, University of Virginia, Charlottesville, VA, United States.
Jane M MaguireFaculty of Health, University of Technology Sydney, Ultimo, NSW, Australia.
Arne LindgrenDepartment of Neurology and Rehabilitation Medicine, Skåne University Hospital, Lund, Sweden.
Christina JernInstitute of Biomedicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
Polina GollandComputer Science and Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Cambridge, MA, United States.
Grégory KuchcinskiInserm, CHU Lille, U1172 - LilNCog (JPARC) - Lille Neurosciences and Cognition, University of Lille, Lille, France.
Natalia S RostJ. Philip Kistler Stroke Research Center, Massachusetts General Hospital, Boston, MA, United States.

Funding

MRI-GENetics Interface Exploration_MRI-GENIE_StudyR01NS086905 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI ROST, NATALIA S · 2015 to 2019
$3.3M
Genetics of Early-Onset Ischemic Stroke ConsortiumR01NS105150 · NINDS · UNIVERSITY OF MARYLAND BALTIMORE · PI KITTNER, STEVEN J, MITCHELL, BRAXTON D · 2018 to 2022
$3.0M
Effects of Vitamin D and Omega-3 on Cerebrovascular DiseaseK01HL128791 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI RIST, PAMELA M. · 2016 to 2020
$858k
NHLBI NIH HHS K01 HL128791NINDS NIH HHS R01 NS086905
6 · The paper itself

Abstract

objectiveNeuroimaging measurements of brain structural integrity are thought to be surrogates for brain health, but precise assessments require dedicated advanced image acquisitions. By means of quantitatively describing conventional images, radiomic analyses hold potential for evaluating brain health. We sought to: (1) evaluate radiomics to assess brain structural integrity by predicting white matter hyperintensities burdens (WMH) and (2) uncover associations between predictive radiomic features and clinical phenotypes.

methodsWe analyzed a multi-site cohort of 4,163 acute ischemic strokes (AIS) patients with T2-FLAIR MR images with total brain and WMH segmentations. Radiomic features were extracted from normal-appearing brain tissue (brain mask-WMH mask). Radiomics-based prediction of personalized WMH burden was done using ElasticNet linear regression. We built a radiomic signature of WMH with stable selected features predictive of WMH burden and then related this signature to clinical variables using canonical correlation analysis (CCA).

resultsRadiomic features were predictive of WMH burden (

conclusionRadiomics extracted from T2-FLAIR images of AIS patients capture microstructural damage of the cerebral parenchyma and correlate with clinical phenotypes, suggesting different radiographical textural abnormalities per cardiovascular risk profile. Further research could evaluate radiomics to predict the progression of WMH and for the follow-up of stroke patients' brain health.

Indexed as

brain healthcerebrovascular disease (CVD)machine learningMRIradiomicsstroke

Identifiers

PMID34321995
PMCPMC8312571

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.